Australia’s Legal Cannabis Market Set to Soar with 16.19% CAGR by 2033
The Australian legal cannabis market is poised for significant growth, driven by increasing demand for medicinal cannabis products and a favorable regulatory environment. According to a recent report, the market is expected to expand from an estimated USD 862.31 million in 2025 to USD 3.05 billion by 2033, representing a compound annual growth rate (CAGR) of 16.19%.
Medical applications are a key driver of growth, with the pharmaceutical sector leading the way. The Australian Government legalized cannabis for medicinal purposes in 2016, establishing a framework for a regulated national industry. The Therapeutic Goods Administration (TGA) oversees the supply of medicinal cannabis products, ensuring regulatory and quality requirements are met.
In addition to medicinal cannabis, the market is also influenced by legislative developments in the Australian Capital Territory (ACT), which permits eligible adults to possess and cultivate cannabis for personal use. This has created opportunities for licensed producers, pharmaceutical companies, healthcare providers, distributors, and product developers.
As the market continues to evolve, companies operating in the sector must remain vigilant and adapt to changing regulatory requirements, patient awareness, and innovation in cannabis derivatives. With ongoing research and development, the Australian legal cannabis market is expected to shape the industry through 2033 and beyond.
